MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
GCTK — GlucoTrack, Inc. Common Stock
NasdaqGlucoTrack, Inc. Common Stock
$1.21
-0.20(-14.18%)
- O
- 1.34
- H
- 1.34
- L
- 1.15
- V
- 281.24K
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About GCTK
GlucoTrack Inc is a medical device company focused on the development of an implantable continuous blood glucose monitor (CBGM) for patients with Type 1 and Type 2 diabetes. The company is developing its Glucotrack CBGM system to provide continuous glucose monitoring using implantable sensor technology and is advancing the product through clinical studies and regulatory processes.
IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
SectorNot available
IPO DateDec 10, 2000
Employees15
Stock ExchangeNasdaq
Ticker SymbolGCTK
Websitehttps://www.glucotrack.com
Key Financial Statistics
| Market Cap | $1.23M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $0.25 - $9.09 |
| 52-Week Avg Volume | 4.16M |
| VWAP | $1.24 |
| Transactions | 2,007 |
| Total Recorded Bars | 3,381 days |